Amoxicillin/Metronidazole/Vonoprazan Fumarate

阿莫西林/甲硝唑/富马酸伏诺拉生

Report date: 2026/03/18 10:10:12

Base Information

Drug NameAmoxicillin/Metronidazole/Vonoprazan Fumarate

Drug Alias Name阿莫西林/甲硝唑/富马酸沃诺拉赞Amoxicillin/Metronidazole/Vonoprazan FumarateVonoprazan Fumarate/Amoxicillin hydrate/MetronidazoleVonopion

ClassificationSmall molecules > Heterocyclic drugs > Antibiotics > β-lactam antibiotics

Mechanisms of ActionPotassium-transporting ATPase inhibitorsDNA synthesis inhibitorsBacterial penicillin-binding protein inhibitors

TargetsPotassium-transporting ATPaseBacterial penicillin-binding protein

Therapy Area/IndicationsHelicobacter pylori infectionPurpura, Thrombocytopenic, IdiopathicStomach Ulcer +[5]

Global Approved IndicationsHelicobacter pylori infectionPurpura, Thrombocytopenic, IdiopathicStomach Ulcer +[5]

Approved Indications in ChinaN/A

Original Approved Country/TerritoryJapan

Original Approved Date2016/02/25

Country/TerritoryJapan

Global Highest StatusApproved

Highest Status in ChinaN/A

China Registration ClassN/A

Inactive CompaniesN/A

Active IndicationsHelicobacter pylori infectionPurpura, Thrombocytopenic, IdiopathicStomach Ulcer +[5]

Inactive IndicationsN/A

ATC CodeA02BD15